. Author manuscript; available in PMC: 2013 Aug 2.

Published in final edited form as: Am J Obstet Gynecol. 2005 Sep;193(3 0 2):1065–1070. doi: 10.1016/j.ajog.2005.05.087

Table 4. Adverse Obstetric Outcomes.

	High-Dose Vaginal Misoprostol (n=20)	Concentrated Oxytocin + Low-dose Vaginal PGE₁ (n=18)	p value

Live Birth ^*	12.5% (2/16)	0.0% (0/15)	0.157
Retained Placenta Requiring Dilation and Curettage	5.0% (1/20)	11.1% (2/18)	0.595
Postpartum Hemorrhage > 500 cc	5.0% (1/20)	0.0% (0/18)	1.000
Hypotensive Reaction Requiring Treatment	0.0% (0/20)	0.0% (0/18)	1.000
Transfusion Required	0.0% (0/20)	0.0% (0/18)	1.000
Uterine Rupture	0.0% (0/20)	0.0% (0/18)	1.000
Chorioamnionitis	5.0% (1/20)	5.6% (1/18)	1.000
Side Effects:
Isolated Fever >100.0 °F	65.0% (13/20)	55.6% (10/18)	0.552
Nausea	25.0% (5/20)	11.1% (2/18)	0.410
Emesis	15.0% (3/20)	5.6% (1/18)	0.606
Diarrhea	0.0% (0/20)	5.6% (1/18)	0.474
Δ Hematocrit % (pre/post) ^†	- 3.5 (-7.0 – 2.0)	-2.0 (-7.0 – 1.0)	0.295

Excludes women with an intrauterine fetal demise at onset of induction

^†

median (range)